Compagnie Lombard Odier SCmA’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,380
| Closed | -$175K | – | 449 |
|
2025
Q1 | $175K | Buy |
+2,380
| New | +$175K | ﹤0.01% | 262 |
|
2024
Q1 | – | Sell |
-400
| Closed | -$26.9K | – | 498 |
|
2023
Q4 | $26.9K | Buy |
+400
| New | +$26.9K | ﹤0.01% | 449 |
|
2022
Q2 | – | Sell |
-500
| Closed | -$33K | – | 591 |
|
2022
Q1 | $33K | Hold |
500
| – | – | ﹤0.01% | 483 |
|
2021
Q4 | $29K | Hold |
500
| – | – | ﹤0.01% | 551 |
|
2021
Q3 | $30K | Sell |
500
-300
| -38% | -$18K | ﹤0.01% | 532 |
|
2021
Q2 | $48K | Hold |
800
| – | – | ﹤0.01% | 492 |
|
2021
Q1 | $40K | Buy |
+800
| New | +$40K | ﹤0.01% | 528 |
|
2018
Q4 | – | Sell |
-140
| Closed | -$6K | – | 537 |
|
2018
Q3 | $6K | Hold |
140
| – | – | ﹤0.01% | 512 |
|
2018
Q2 | $5K | Hold |
140
| – | – | ﹤0.01% | 554 |
|
2018
Q1 | $5K | Sell |
140
-486
| -78% | -$17.4K | ﹤0.01% | 561 |
|
2017
Q4 | $22K | Buy |
626
+486
| +347% | +$17.1K | ﹤0.01% | 563 |
|
2017
Q3 | $5K | Hold |
140
| – | – | ﹤0.01% | 644 |
|
2017
Q2 | $5K | Hold |
140
| – | – | ﹤0.01% | 664 |
|
2017
Q1 | $4K | Sell |
140
-2,000
| -93% | -$57.1K | ﹤0.01% | 687 |
|
2016
Q4 | $59K | Sell |
2,140
-4,000
| -65% | -$110K | ﹤0.01% | 588 |
|
2016
Q3 | $202K | Hold |
6,140
| – | – | 0.01% | 473 |
|
2016
Q2 | $185K | Hold |
6,140
| – | – | 0.01% | 484 |
|
2016
Q1 | $173K | Buy |
6,140
+2,000
| +48% | +$56.4K | 0.01% | 514 |
|
2015
Q4 | $141K | Buy |
4,140
+1,340
| +48% | +$45.6K | ﹤0.01% | 536 |
|
2015
Q3 | $89K | Hold |
2,800
| – | – | ﹤0.01% | 537 |
|
2015
Q2 | $89K | Hold |
2,800
| – | – | ﹤0.01% | 574 |
|
2015
Q1 | $96K | Buy |
2,800
+2,600
| +1,300% | +$89.1K | ﹤0.01% | 669 |
|
2014
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 728 |
|
2014
Q3 | $7K | Hold |
200
| – | – | ﹤0.01% | 834 |
|
2014
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 849 |
|
2014
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 839 |
|
2013
Q4 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 827 |
|